Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
Yangfeng Li ; Zhengnan Shen ; Kiira Ratia , et al. JMC,2024,67(4):2712-2731. DOI: 10.1021/acs.jmedchem.3c01837
More
Abstract: The bromodomain and extra-terminal domain (BET) proteins are epigenetic readers, regulating transcription via two highly homologous tandem bromodomains, BD1 and BD2. Clinical development of nonselective pan-BD BET inhibitors has been challenging, partly due to dose-limiting side effects such as thrombocytopenia. This has prompted the push for domain-selective BET inhibitors to achieve a more favorable therapeutic window. We report a structure-guided drug design campaign that led to the development of a potent BD1-selective BET inhibitor, 33 (XL-126), with a Kd of 8.9 nM and 185-fold BD1/BD2 selectivity. The high selectivity was first assayed by SPR, validated by a secondary time-resolved fluorescence energy transfer assay, and further corroborated by BROMOscan (~57–373 fold selectivity). The cocrystal of 33 with BRD4 BD1 and BD2 demonstrates the source of selectivity: repulsion with His437 and lost binding with the leucine clamp. Notably, the BD1 selectivity of BET inhibitor 33 leads to both the preservation of platelets and potent anti-inflammatory efficacy.
Purchased from AmBeed: 910543-72-5 ; 56-84-8 ; 71-00-1 ; 944937-53-5 ; 1793016-39-3 ; 50618-82-1
CAS No. : | 944937-53-5 | MDL No. : | MFCD09266227 |
Formula : | C7H5BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OJFFFCVPCVATIV-UHFFFAOYSA-N |
M.W : | 197.03 | Pubchem ID : | 24229256 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; water; at 150℃; for 0.5h;Sealed tube; Inert atmosphere; Microwave irradiation; | mixture of 6-bromo-lH-pyrrolo[3,2-b]pyridine (CAS: 944937-53-5; 75 mg, 0.38 mmol), tert-butyl 5-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H- pyridine- 1-carboxylate (CAS: 1251537-34-4; 129.5 mg, 0.42 mmol) and Pd(PPh3)4 (CAS: 14221-01-3; 44 mg, 0.04 mmol) in 1,4-dioxane (1.5 mL) and Na2C03 (0.75 mL; aq. sat. soltn.) in a sealed tube and under nitrogen atmosphere was stirred at 150 °C for 30 minutes under microwave irradiation. The reaction mixture was diluted with EtOAc and washed with water. The organic layer was separated, dried (Na2S04), filtered and the solvent evaporated in vacuo. The residue was purified by flash chromatography (silica, EtOAc in DCM from 0/100 to 100/0). The desired fractions were collected and concentrated in vacuo affording intermediate 56 as a pale yellow solid (100 mg, 88percent yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31% | With copper(l) iodide; (1S,2S)-N,N'-dimethyl-1,2-diaminocyclohexane; caesium carbonate; In 1,4-dioxane; at 150℃; for 2h;Microwave irradiation; | To a stirred solution of 6-bromo-1H-pyrrolo[3,2-b]pyridine (6-a) (400 mg, 2.030 mol) in 1,4-dioxane (8 mL) was added <strong>[5460-32-2]4-iodo-1,2-dimethoxybenzene</strong> (536 mg, 2.030 mol), (1S,2S)-N1,N2- dimethylcyclohexane-1,2-diamine (58 mg, 0.406 mmol), CuI (39 mg, 0.203 mmol) and Cs2CO3 (1.32 g, 4.060 mmol). The mixture was placed in a microwave and heated at 150 for 2 h. The mixture was concentrated and purified (silica gel; eluting with EtOAc/PE= 1/50-1/10) to afford compound 6-b (206 mg, 31%) as an off-white solid.1H NMR (400 MHz, DMSO-d6) d 8.63- 8.40 (m, 1H), 8.22- 8.02 (m, 1H), 7.94 (dd, J = 26.8, 3.3 Hz, 1H), 7.14 (d, J = 10.3 Hz, 3H), 6.86- 6.74 (m, 1H), 3.83 (s, 6H); LCMS Mass: 333.0 (M++H). |
[ 1190319-51-7 ]
6-Bromo-2-methyl-1H-pyrrolo[3,2-b]pyridine
Similarity: 1.00
[ 1086064-46-1 ]
6-Bromo-1-methyl-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.95
[ 1190312-27-6 ]
6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carbaldehyde
Similarity: 0.82
[ 914358-73-9 ]
5-Bromo-2-methylpyridin-3-amine
Similarity: 0.81
[ 1190319-51-7 ]
6-Bromo-2-methyl-1H-pyrrolo[3,2-b]pyridine
Similarity: 1.00
[ 1086064-46-1 ]
6-Bromo-1-methyl-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.95
[ 73177-35-2 ]
2-Methyl-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.83
[ 1190312-27-6 ]
6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carbaldehyde
Similarity: 0.82